NGFR and metabolic disease: Adipocyte-specific p75NTR knockout or transplantation of WAT from p75NTR−/− into wild-type mice fed a HFD protects mice against weight gain and insulin resistance; thus, the p75NTR/PKA signaling pathway is a potential therapeutic target for metabolic disorders (65).